Nifty Smallcap250 Quality 50 News and Updates

Name: Latest research reports of Triveni Turbine Ltd. authored by Sharekhan and published by - Trendlyne research reports.
Item: Triveni Turbine Ltd.
Rating: 5
Author: Sharekhan

Keep track of all breaking news on Nifty Smallcap250 Quality 50 from all sources in a single place.

Load latest

Indian Energy Exchange Ltd.

04 Sep 2025

141.18

1.43%

Spot power trade volumes jump 19% in August; average price drops 7%

Business Standard

Indian Energy Exchange reports a 19% increase in power trade volumes in August 2025, while average prices drop 7% year-on-year, presenting an opportunity for discoms and industrial consumers

Indian Energy Exchange Ltd. has lost -30.89% in the last 1 Year

IEX electricity trade rises nearly 19% to 11,803 million units in Aug

Business Standard | 04 Sep 2025

Motilal Oswal Financial Services Ltd.

04 Sep 2025

900.10

0.73%

L&T Finance Balancing Growth, Asset Quality Amid Macro Headwinds, Says Motilal Oswal Maintaining 'Buy'

NDTV Profit

L&T Finance will soon emerge out of the MFI credit cycle and will continue to deliver better profitability and RoA expansion, adds Motilal Oswal

Motilal Oswal Financial Services Ltd. has gained 46.27% in the last 6 Months

Triveni Turbine Ltd.

04 Sep 2025

523.60

0.90%

Set for a long race

Buy: Triveni Turbine Ltd.

Sharekhan

Triveni Turbines Ltd had a moderate Q1FY26, due to geopolitical tensions and tariff escalations, but the long-term prospects remain robust with major recovery from H2FY26.

Triveni Turbine Ltd. has an average target of 651.40 from 5 brokers.

Mahanagar Gas Ltd.

04 Sep 2025

1277.00

-1.40%

Initiating Coverage:Mahanagar Gas

Buy: Mahanagar Gas Ltd.

Axis Direct

We initiate coverage on Mahanagar Gas Limited (MGL) with a BUY recommendation and a target price of Rs 1,540/share, implying a potential upside of 20% from the current market price (CMP)

Number of FII/FPI investors increased from 320 to 366 in Jun 2025 qtr.

Pfizer Ltd.

03 Sep 2025

5151.00

2.28%

Pfizer Defends Covid Shot, Says Trump Deserves Nobel Prize

NDTV Profit

Vaccines have become a political flashpoint in recent years, with pundits questioning widely accepted evidence about their safety and efficacy.

Pfizer Ltd. average weekly volume is high.

Caplin Point Laboratories Ltd.

03 Sep 2025

2058.50

4.70%

Caplin Point's unit gets USFDA nod for generic milrinone lactate injection

Business Standard

Pharma firm Caplin Point Laboratories Ltd on Wednesday said its arm Caplin Steriles Ltd has received final approval from the US health regulator for its generic milrinone lactate in 5 per cent dextrose injection indicated for the short-term intravenous treatment of patients with acute decompensated heart failure. The approval granted by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) milrinone lactate in 5 per cent Dextrose Injection of strengths 20 mg/100 mL and 40 mg/200 mL in single-dose infusion bags, Caplin Point Laboratories said in a regulatory filing. The approved injection is a generic therapeutic equivalent version of the reference listed drug PRIMACOR in dextrose 5 per cent, by Sanofi Aventis US LLC, it added. Milrinone is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure, the company said. Citing IQVIA (IMS Health) data, the company said milrinone lactate in 5 per cent...

Caplin Point Laboratories Ltd. is trading below all available SMAs

AstraZeneca Pharma India Ltd.

02 Sep 2025

9222.00

1.28%

AstraZeneca surrenders its manufacturing licence in India

Business Line

The company is looking at importing its products from the 20-odd facilities it has across the world as part of a global review, said a source

Number of FII/FPI investors increased from 164 to 181 in Jun 2025 qtr.

Dr. Lal Pathlabs Ltd.

02 Sep 2025

3168.70

1.62%

DR. LAL PATHLABS LIMITED

Hold: Dr. Lal Pathlabs Ltd.

Target

Geojit BNP Paribas

*over or under performance to benchmark index Dr Lal PathLabs Ltd (DLPL) provides diagnostic tests and services globally. As of December 2024, DLPL had 280 clinical laboratories, including a national reference lab...